MPIBX Performance — BNY Mellon Intermediate Bond Fund, Class M
Data updated: 2026-01-26
MPIBX returned +5.80% over one year to Nov 2025. Annualised returns are +4.78% over 3 years and +1.27% over 5 years. Against its Intermediate Government Bond category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $115, against $113 for the category, and to $106 over one year, against $106. Volatility over the past three years was 3.02% a year. In the 12 months to Nov 2025 the fund lost a net $62.2M, and assets reached $414.92M.
MPIBX Growth of $100
What $100 invested in BNY Mellon Intermediate Bond Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Intermediate Government Bond category average over the same months.
| Period | MPIBX | Category average |
|---|---|---|
| 1 year (Dec 2024 – Nov 2025) | $106 | $106 |
| 3 years (Dec 2022 – Nov 2025) | $115 | $113 |
| 5 years (Dec 2020 – Nov 2025) | $107 | $103 |
| Since data start (Sep 2019 – Nov 2025) | $112 | $111 |
MPIBX Trailing Returns
Total returns to Nov 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +5.80% |
| 3 years (annualised) | +4.78% |
| 5 years (annualised) | +1.27% |
MPIBX Annual Returns
Calendar-year total returns of BNY Mellon Intermediate Bond Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–Nov) | +6.52% |
| 2024 | +2.70% |
| 2023 | +5.27% |
| 2022 | −6.81% |
| 2021 | −1.04% |
| 2020 | +5.56% |
| 2019 (Sep–Dec) | +0.33% |
MPIBX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +0.5% | +1.5% | +0.4% | +0.8% | −0.3% | +1.0% | −0.1% | +1.2% | +0.4% | +0.4% | +0.6% | — |
| 2024 | +0.5% | −0.7% | +0.5% | −0.9% | +1.1% | +0.6% | +1.5% | +1.0% | +0.9% | −1.6% | +0.6% | −0.7% |
| 2023 | +1.6% | −1.2% | +1.8% | +0.4% | −0.4% | −0.4% | +0.3% | +0.1% | −0.5% | −0.1% | +2.1% | +1.6% |
| 2022 | −1.2% | −0.8% | −1.8% | −1.5% | +0.4% | −1.1% | +1.2% | −1.4% | −2.0% | −0.3% | +1.6% | −0.1% |
| 2021 | −0.1% | −0.6% | −0.5% | +0.5% | +0.3% | 0.0% | +0.6% | −0.1% | −0.3% | −0.5% | −0.1% | 0.0% |
| 2020 | +1.1% | +1.0% | −1.6% | +1.7% | +0.8% | +0.9% | +0.9% | +0.1% | −0.1% | −0.2% | +0.7% | +0.3% |
| 2019 | — | — | — | — | — | — | — | — | −0.2% | +0.4% | −0.1% | +0.3% |
MPIBX Risk
Risk measures from monthly returns over Dec 2022 – Nov 2025.
- 3-year volatility (annualised): 3.02%
- 3-year Sharpe ratio: 0.09 (vs 4.5% risk-free rate)
- Best month: +2.07% (Nov 2023)
- Worst month: −1.64% (Oct 2024)
MPIBX Fund Flows
Monthly money in and out of BNY Mellon Intermediate Bond Fund, from SEC Form N-PORT.
- 12-month net flow: −$62.2M
- 12-month gross sales (incl. reinvestments): $62.9M
- Sales ÷ redemptions: 0.50×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Nov 2025 | $4.0M | $5.9M | −$1.9M |
| Oct 2025 | $2.5M | $6.7M | −$4.2M |
| Sep 2025 | $5.5M | $9.9M | −$4.3M |
| Aug 2025 | $3.9M | $9.1M | −$5.2M |
| Jul 2025 | $7.0M | $5.6M | $1.3M |
| Jun 2025 | $7.5M | $5.8M | $1.7M |
| May 2025 | $4.8M | $13.1M | −$8.2M |
| Apr 2025 | $10.6M | $8.2M | $2.4M |
| Mar 2025 | $3.4M | $22.3M | −$18.8M |
| Feb 2025 | $4.9M | $12.7M | −$7.8M |
| Jan 2025 | $2.6M | $14.8M | −$12.2M |
| Dec 2024 | $6.1M | $11.0M | −$4.9M |
MPIBX Assets Under Management
Net assets of BNY Mellon Intermediate Bond Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-11-30 | $414.92M |
| 2025-08-31 | $423.26M |
| 2025-05-31 | $420.28M |
| 2025-02-28 | $444.99M |
| 2024-11-30 | $468.45M |
| 2024-08-31 | $479.44M |
| 2024-05-31 | $473.18M |
| 2024-02-29 | $488.41M |
| 2023-11-30 | $492.82M |
| 2023-08-31 | $514.88M |
| 2023-05-31 | $544.89M |
| 2023-02-28 | $571.66M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.